BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17181864)

  • 1. HIV-1 Tat interaction with Dicer: requirement for RNA.
    Bennasser Y; Jeang KT
    Retrovirology; 2006 Dec; 3():95. PubMed ID: 17181864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PACT in the RNA silencing pathway.
    Lee Y; Hur I; Park SY; Kim YK; Suh MR; Kim VN
    EMBO J; 2006 Feb; 25(3):522-32. PubMed ID: 16424907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
    Bennasser Y; Le SY; Benkirane M; Jeang KT
    Immunity; 2005 May; 22(5):607-19. PubMed ID: 15894278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.
    Chendrimada TP; Gregory RI; Kumaraswamy E; Norman J; Cooch N; Nishikura K; Shiekhattar R
    Nature; 2005 Aug; 436(7051):740-4. PubMed ID: 15973356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of microRNA-silencing pathway by HIV-1 during virus replication.
    Triboulet R; Mari B; Lin YL; Chable-Bessia C; Bennasser Y; Lebrigand K; Cardinaud B; Maurin T; Barbry P; Baillat V; Reynes J; Corbeau P; Jeang KT; Benkirane M
    Science; 2007 Mar; 315(5818):1579-82. PubMed ID: 17322031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
    Wu-Baer F; Sigman D; Gaynor RB
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7153-7. PubMed ID: 7638159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA.
    Gallia GL; Darbinian N; Tretiakova A; Ansari SA; Rappaport J; Brady J; Wortman MJ; Johnson EM; Khalili K
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11572-7. PubMed ID: 10500218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
    Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
    Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR.
    Klase Z; Kale P; Winograd R; Gupta MV; Heydarian M; Berro R; McCaffrey T; Kashanchi F
    BMC Mol Biol; 2007 Jul; 8():63. PubMed ID: 17663774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways.
    Lee YS; Nakahara K; Pham JW; Kim K; He Z; Sontheimer EJ; Carthew RW
    Cell; 2004 Apr; 117(1):69-81. PubMed ID: 15066283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 Tat transactivator protein: a therapeutic target?
    Fulcher AJ; Jans DA
    IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of DICER in monocytes and its regulation by HIV-1.
    Coley W; Van Duyne R; Carpio L; Guendel I; Kehn-Hall K; Chevalier S; Narayanan A; Luu T; Lee N; Klase Z; Kashanchi F
    J Biol Chem; 2010 Oct; 285(42):31930-43. PubMed ID: 20584909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer.
    Tahbaz N; Kolb FA; Zhang H; Jaronczyk K; Filipowicz W; Hobman TC
    EMBO Rep; 2004 Feb; 5(2):189-94. PubMed ID: 14749716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.
    Brès V; Kiernan RE; Linares LK; Chable-Bessia C; Plechakova O; Tréand C; Emiliani S; Peloponese JM; Jeang KT; Coux O; Scheffner M; Benkirane M
    Nat Cell Biol; 2003 Aug; 5(8):754-61. PubMed ID: 12883554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.